Erschienen in:
01.12.2018 | Short Communication
Selective serotonin reuptake inhibitor effects on neural biomarkers of perinatal depression
verfasst von:
Jodi L. Pawluski, Ursula Brain, Geoffrey L. Hammond, Tim F. Oberlander
Erschienen in:
Archives of Women's Mental Health
|
Ausgabe 3/2019
Einloggen, um Zugang zu erhalten
Abstract
The effect of perinatal selective serotonin reuptake inhibitors (SSRIs) on brain-derived neurotrophic factor (BDNF) and S100 calcium binding protein B (S100B) has not been investigated. Using a cohort of 86 pregnant women, we found that SSRIs significantly increase BDNF levels in late pregnancy and that S100B, but not BDNF, is associated with maternal depression in SSRI-treated women only. This shows that serum S100B could be a unique biomarker to determine efficacy of SSRIs during gestation.